Stock Events

Stock Events

NRX Pharmaceuticals 

$3.44
110
+$0.01+0.29% Tuesday 19:59
-$0.12-3.61%Tuesday 23:56After hours

Statistics

Day High
3.46
Day Low
3.44
52W High
5.06
52W Low
1.62
Volume
34,181
Avg. Volume
-
Mkt Cap
147.23M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.98
-0.58
-0.19
0.21
Expected EPS
-0.11
Actual EPS
N/A

Financials

-2,336.49%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.23MRevenue
-28.62MNet Income

Analyst Ratings

34.50Average Price Target
The highest estimate is 49.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NRXP. It's not an investment recommendation.
Tesla
17
TSLA
Apple
13
AAPL
NVIDIA
13
NVDA
Microsoft
12
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap152.69B
Pfizer is a global pharmaceutical company that competes with NRX Pharmaceuticals in the development and marketing of medications for various therapeutic areas, including mental health.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its pharmaceutical segment Janssen, competes in developing treatments for disorders that NRX Pharmaceuticals targets, including mental health and other areas.
Merck
MRK
Mkt Cap335.14B
Merck & Co. is involved in the research, development, and marketing of drugs that address conditions similar to those targeted by NRX Pharmaceuticals, making them a direct competitor.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly and Company competes with NRX Pharmaceuticals in the psychiatric and neurological drug market, particularly in areas like depression and bipolar disorder.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie competes in the neuroscience and mental health drug market, areas that are of interest to NRX Pharmaceuticals, with a strong portfolio in psychiatric drugs.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol Myers Squibb offers a range of products that compete in the therapeutic areas targeted by NRX Pharmaceuticals, including mental health treatments.
Novartis
NVS
Mkt Cap286.78B
Novartis AG competes with NRX Pharmaceuticals through its extensive research and development in therapies for neurological and mental health conditions.
GSK
GSK
Mkt Cap99.18B
GlaxoSmithKline competes in the pharmaceutical market for mental health medications, a key area of focus for NRX Pharmaceuticals.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.85B
Teva Pharmaceutical Industries is a global competitor in generic and specialty medicines, including those for neurological and psychiatric conditions that NRX Pharmaceuticals also targets.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca is involved in the development of therapies for various diseases, including those in the neurological and psychiatric domain, making them a competitor to NRX Pharmaceuticals.

About

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Show more...
CEO
Jonathan C. Javitt
Employees
29
Country
United States
ISIN
US6294442099
WKN
000A4091K

Listings

MU
DE
B1Q.MU
XNAS
US
NRXP
STU
DE
B1Q.STU
F
DE
B1Q.F

0 Comments

Share your thoughts

FAQ

What is NRX Pharmaceuticals stock price today?▼
The current price of NRXP is $3.44 USD — it has increased by +0.29% in the past 24 hours. Watch NRX Pharmaceuticals stock price performance more closely on the chart.
What is NRX Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange NRX Pharmaceuticals stocks are traded under the ticker NRXP.
Is NRX Pharmaceuticals stock price growing?▼
NRXP stock has risen by +2.38% compared to the previous week, the month change is a -19.44% fall, over the last year NRX Pharmaceuticals has showed a +37.33% increase.
What is NRX Pharmaceuticals market cap?▼
Today NRX Pharmaceuticals has the market capitalization of 147.23M
When is the next NRX Pharmaceuticals earnings date?▼
NRX Pharmaceuticals is going to release the next earnings report on November 16, 2026.
What were NRX Pharmaceuticals earnings last quarter?▼
NRXP earnings for the last quarter are -0.44 USD per share, whereas the estimation was -0.11 USD resulting in a -312.5% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is NRX Pharmaceuticals revenue for the last year?▼
NRX Pharmaceuticals revenue for the last year amounts to 1.23M USD.
What is NRX Pharmaceuticals net income for the last year?▼
NRXP net income for the last year is -28.62M USD.
How many employees does NRX Pharmaceuticals have?▼
As of August 19, 2026, the company has 29 employees.
In which sector is NRX Pharmaceuticals located?▼
NRX Pharmaceuticals operates in the Health & Wellness sector.
When did NRX Pharmaceuticals complete a stock split?▼
The last stock split for NRX Pharmaceuticals was on April 02, 2024 with a ratio of 1:10.
Where is NRX Pharmaceuticals headquartered?▼
NRX Pharmaceuticals is headquartered in WILMINGTON, United States.